2024 – Artrya

Our Solution
- Physicians
- Patients
About Artrya
Investor Relations
Contact Us

Request a demonstration

Notification of cessation of securities – AYA

Notification regarding unquoted securities – AYA

Issue of Unquoted Securities

Notification regarding unquoted securities – AYA

Application for quotation of securities – AYA

Cleansing Notice

Results of Meeting

2024 AGM Chair Address and CEO Presentation

Annual General Meeting Link

Ceasing to be a substantial holder

1 2 3 4 5 Next

Precise diagnosis. Personalized treatment.
Preventative care.

Choose Artrya as your trusted clinical partner.

Contact us today

Coronary artery disease.

We see you.

Sign up to our newsletter

Request a Demo
Contact Us

About Artrya
Investor Relations

Location

1257 Hay Street, West Perth, 6005

Follow us

X

LinkedIn

Salix Coronary Anatomy is listed on the Australian Register of Therapeutic Goods, ID 347719. Salix Coronary Anatomy USA product (K243038) is cleared in the USA.
For the availability of Salix in the EU, UK, US or other jurisdictions, please contact us.

© 2025, Artrya. All rights reserved. Privacy Policy Terms and Conditions Indications for Use